Loan Loss Reserves / Non-Performing Loans (Annual)

Loan Loss Reserves / Non-Performing Loans: Allowance for bad loans as a portion of total loans made. Calculated as: Loan Loss Reserves / Non-Performing Loans

TELA Bio, Inc. (TELA) Loan Loss Reserves / Non-Performing Loans data is not available.

Quarterly Annual

Figures for fiscal year ending 2024-12-31

Income Statement Financials
Revenue	$69.30M
Net Income	$-37.84M
Cost of Goods Sold	$22.43M
Gross Profit	$46.87M
Operating Expenses	$103.42M
Operating Income	$-34.12M
Non-Operating Income/Expense	$-3.87M
Pre-Tax Income	$-37.98M
Normalized Pre-Tax Income	$-37.98M
Income after Taxes	$-37.84M
Income from Continuous Operations	$-37.84M
Consolidated Net Income/Loss	$-37.84M
Normalized Income after Taxes	$-37.84M
EBIT	$-34.12M
EBITDA	$-33.10M
Weighted-Average Shares Outstanding (Basic)	28.53M
Weighted-Average Shares Outstanding (Diluted)	28.53M
Earnings per Share (EPS) (Basic)	$-1.33
Earnings per Share (EPS) (Diluted)	$-1.33
Balance Sheet Financials
Current Assets	$78.07M
Property, Plant, and Equipment	$2.34M
Long-Term Assets	$8.50M
Total Assets	$86.57M
Current Liabilities	$15.60M
Long-Term Debt	$41.12M
Long-Term Liabilities	$42.51M
Total Liabilities	$58.11M
Common Equity	$28.46M
Tangible Shareholders Equity	$26.72M
Shareholders Equity	$28.46M
Common Shares Outstanding	39.40M
Cash Flow Statement Financials
Cash Flow from Operating Activities	$-41.59M
Cash Flow from Investing Activities	$4.45M
Cash Flow from Financial Activities	$43.06M
Beginning Cash	$46.99M
End Cash	$52.94M
Increase/Decrease in Cash	$5.94M
Stock-Based Compensation	$4.36M
Common Stock Dividends Paid	--
Preferred Stock Dividends Paid	--
Fundamental Metrics & Ratios
Current Ratio	5.01
Non-Performing Assets / Total Loans	--
Loan Loss Reserves / Non-Performing Loans	--
Debt to Capital Ratio	0.59
Debt to Equity Ratio	1.45
Gross Margin	67.63%
Operating Margin	-49.23%
EBIT Margin	-49.23%
EBITDA Margin	-47.77%
Pre-Tax Profit Margin	-54.81%
Profit Margin	-54.60%
Free Cash Flow	$-42.58M
Loss Ratio	--
Expense Ratio	--
Combined Ratio	--
Asset Turnover	0.80
Inventory Turnover	1.76
Receiveable Turnover	6.86
Days Sales in Receivables	53.19
Return on Equity	-132.97%
Return on Tangible Equity	-141.63%
Return on Assets	-43.71%
Return on Investments	-54.38%
Book Value Per Share	$0.72
Free Cash Flow per Share	$-1.49
Operating Cash Flow per Share	$-1.46

Data from Zacks Investment Research, Inc.